When comparing KRAS G12C mutant cases with the rest of the cohort, proximal tumours were less likely to carry the KRAS G12C mutation compared to distal tumours (OR 0.652, 95% CI 0.451–0.944, p = 0.024). Here, KRAS is linked to neoplasm.